Computational dreams and catmint schemes
At the Wellcome Sanger Institute, Xiaotian Liao navigates a world of protein puzzles, global experiences and furry friends, blending curiosity and computation into a journey that stretches far beyond the lab.
Unlocking the genetics of skin cancer
Dr David Adams, Senior Group Leader at the Wellcome Sanger Institute, is a pioneer in cancer biology and uncovering skin cancer genetics. We explore his 20-year career at Sanger and the global impact of his research.
Celebrating COSMIC and 20 years of enhancing cancer research
In 2024, COSMIC – the world’s largest and most comprehensive resource on genetic mutations in cancer – celebrates two exciting milestones: COSMIC reaches its 20th anniversary and releases its 100th version of the database.
Revealing the genetics of the immune system and pregnancy
Emma Davenport explains how her career has evolved from genetics to computational biology and shares her experience as a female faculty member at the Sanger Institute.
20 Things We Learned in 2020
This has been a year that none of us will forget in a hurry. The Institute is immensely proud of the way our staff have pulled together, and the work we have managed to achieve
Sepsis and precision medicine: is it all in your genes?
Using gene expression data to stratify patients.
What if medicine could be tailored ‘just for you’?
The information in our genomes is helping doctors diagnose and treat disease. But how far can personalised medicine go?
I’ve never had chickenpox, what’s your superpower?
Gary Dillon, Business Development Manager at the Sanger Institute gives us his view on some of the powers and pitfalls of genomics.
A new deal on data – articulating the contract between science and people
Now is the time for scientists to strike a deal everyone that benefits society as well as research, argue Anna Middleton, Vivienne Parry and Julian Borra
